BR112022022292A2 - Formas polimórficas de cloridrato de (r)-oxibutinina - Google Patents

Formas polimórficas de cloridrato de (r)-oxibutinina

Info

Publication number
BR112022022292A2
BR112022022292A2 BR112022022292A BR112022022292A BR112022022292A2 BR 112022022292 A2 BR112022022292 A2 BR 112022022292A2 BR 112022022292 A BR112022022292 A BR 112022022292A BR 112022022292 A BR112022022292 A BR 112022022292A BR 112022022292 A2 BR112022022292 A2 BR 112022022292A2
Authority
BR
Brazil
Prior art keywords
polymorphic forms
oxybutynin
oxybutynin hydrochloride
forms
hcl
Prior art date
Application number
BR112022022292A
Other languages
English (en)
Inventor
Molnar Dennis
Johnston Sean
Original Assignee
Apnimed Inc Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apnimed Inc Delaware filed Critical Apnimed Inc Delaware
Priority claimed from PCT/US2021/030571 external-priority patent/WO2021226020A1/en
Publication of BR112022022292A2 publication Critical patent/BR112022022292A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/20—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C219/22—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/20—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

FORMAS POLIMÓRFICAS DE CLORIDRATO DE (R)-OXIBUTININA. A presente invenção refere-se a formas polimórficas de HCl de (R)-oxibutinina, incluindo três formas cristalinas, são preparadas e caracterizadas. Os usos das várias formas polimórficas de HCl de (R)-oxibutinina para tratamento de Apneia Obstrutiva do Sono (OSA) também são divulgados.
BR112022022292A 2020-05-05 2021-05-04 Formas polimórficas de cloridrato de (r)-oxibutinina BR112022022292A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063020301P 2020-05-05 2020-05-05
US202163136691P 2021-01-13 2021-01-13
PCT/US2021/030571 WO2021226020A1 (en) 2020-05-05 2021-05-04 Polymorphic forms of (r)-oxybutynin hydrochloride

Publications (1)

Publication Number Publication Date
BR112022022292A2 true BR112022022292A2 (pt) 2022-12-20

Family

ID=84324668

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022022292A BR112022022292A2 (pt) 2020-05-05 2021-05-04 Formas polimórficas de cloridrato de (r)-oxibutinina

Country Status (12)

Country Link
US (1) US20230286900A1 (pt)
EP (1) EP4146621A1 (pt)
JP (1) JP2023524783A (pt)
KR (1) KR20230008120A (pt)
CN (1) CN115667205A (pt)
AU (1) AU2021268618A1 (pt)
BR (1) BR112022022292A2 (pt)
CA (1) CA3177654A1 (pt)
CO (1) CO2022016965A2 (pt)
CR (1) CR20220617A (pt)
IL (1) IL297877A (pt)
MX (1) MX2022013823A (pt)

Also Published As

Publication number Publication date
KR20230008120A (ko) 2023-01-13
CA3177654A1 (en) 2021-11-11
CO2022016965A2 (es) 2022-12-09
JP2023524783A (ja) 2023-06-13
US20230286900A1 (en) 2023-09-14
AU2021268618A1 (en) 2022-12-15
IL297877A (en) 2023-01-01
CR20220617A (es) 2023-02-09
CN115667205A (zh) 2023-01-31
EP4146621A1 (en) 2023-03-15
MX2022013823A (es) 2023-01-11

Similar Documents

Publication Publication Date Title
CY1120073T1 (el) Παραγωγα πυραζολο-αμινοπυριμιδινης ως ρυθμιστες της lrrk2
NZ750290A (en) Amino pyrimidine ssao inhibitors
NO20085257L (no) Purinonderivater som HM74a-agonister
NZ599345A (en) Immunogens from uropathogenic Escherichia Coli
BRPI0721088B8 (pt) processo para a preparação de derivados de piperazinil e diazepanil benzamida
PE20141598A1 (es) Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina
CU24053B1 (es) Sales de disacarina, ácido difumárico, ácido di-1-hidroxi-2-naftoico y ácido monobenzoico del 2-(4-((2-amino-4-metil-6-(pentilamino)pirimidin-5-il)metil)fenil)acetato de 4-(dimetilamino)butilo
CY1111287T1 (el) Χρηση της αγομελατινης για την ληψη φαρμακων που προοριζονται για την θεραπεια της διαταραχης γενικευμενου αγχους
BRPI0918580B8 (pt) polimorfo cristalino b da n-(2-aminofenil)-4-[n-(piridina3-il)metóxi-carbonilaminometil]-benzamida, composição e combinação contendo o mesmo, uso e seu processo de produção
MY155230A (en) Sulfoximine-substituted aniline pyrimidine derivatives as cdk inhibitors, their manufacture and use as medicine
NO20066010L (no) 2-(1h-indolylsulfanyl)-aryl-aminderivater for anvendelse i behandlingen av affektive lidelser, smerte, adhd og stressurininkontinens
EA201991921A1 (ru) Способы получения ag-10, его промежуточных соединений и их солей
CL2022003056A1 (es) Formas polimórficas de clorhidrato de (r)-oxibutinina
BR112022022292A2 (pt) Formas polimórficas de cloridrato de (r)-oxibutinina
BR112012013918A2 (pt) inibidores de diacil glicerol acil transferase
MX2022011179A (es) Uso medico de daridorexant.
BR112023025387A2 (pt) Usos de tirzepatida
CY1111430T1 (el) Χρηση της αγομελατινης για τη ληψη φαρμακων που προοριζονται για τη θεραπεια του συνδρομου smith magenis
EP3914203A4 (en) METHODS OF TREATMENT OF OBSTRUCTIVE SLEEP APNEA
CY1114743T1 (el) Νεα χρηση της συνθεσης που περιεχει χλωροπροκαϊνη hcl, νεα συνθεση που περιεχει χλωροπροκαϊνη hcl και μεθοδος παρασκευης της
BR112015001524A2 (pt) composto, processo para a preparação de um composto, composição farmacêutica, método para o tratamento de déficits cognitivos e uso de um composto
GB202002560D0 (en) Crystalline forms of voxelotor, and processes for the preparation thereof
ATE295845T1 (de) Prucaloprid-n-oxid
WO2007107696A3 (en) Pharmaceutically acceptable salts and polymorphic forms
WO2015044952A3 (en) Tramadol hydrochloride and paracetamol orally disintegrating composition and process for preparing the same